TNFR1 signaling resistance associated with female stem cell cytokine production is independent of TNFR2-mediated pathways

Troy A. Markel, Paul R. Crisostomo, Meijing Wang, Yue Wang, Tim Lahm, Nathan M. Novotny, Jiangning Tan, Daniel R. Meldrum

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

End-organ ischemia is a common source of patient morbidity and mortality. Stem cell therapy represents a novel treatment modality for ischemic diseases and may aid injured tissues through the release of beneficial paracrine mediators. Female bone marrow mesenchymal stem cells (MSCs) have demonstrated a relative resistance to detrimental TNF receptor 1 (TNFR1) signaling and are thought to be superior to male stem cells in limiting inflammation. However, it is not known whether sex differences exist in TNF receptor 2 (TNFR2)-ablated MSCs. Therefore, we hypothesized that 1) sex differences would be observed in wild-type (WT) and TNFR2-ablated MSC cytokine signaling, and 2) the production of IL-6, VEGF, and IGF-1 in males, but not females, would be mediated through TNFR2. MSCs were harvested from male and female WT and TNFR2 knockout (TNFR2KO) mice and were subsequently exposed to TNF (50 ng/ml) or LPS (100 ng/ml). After 24 h, supernatants were collected and measured for cytokines. TNF and LPS stimulated WT stem cells to produce cytokines, but sex differences were only seen in IL-6 and IGF-1 after TNF stimulation. Ablation of TNFR2 increased VEGF and IGF-1 production in males compared with wild-type, but no difference was observed in females. Female MSCs from TNFR2KOs produced significantly lower levels of VEGF and IGF-1 compared with male TNFR2KOs. The absence of TNFR2 signaling appears to play a greater role in male MSC cytokine production. As a result, male, but not female stem cell cytokine production may be mediated through TNFR2 signaling cascades.

Original languageEnglish
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume295
Issue number4
DOIs
StatePublished - Oct 2008

Fingerprint

Tumor Necrosis Factor Receptors
Stem Cells
Mesenchymal Stromal Cells
Cytokines
Insulin-Like Growth Factor I
Sex Characteristics
Vascular Endothelial Growth Factor A
Interleukin-6
Cell- and Tissue-Based Therapy
Knockout Mice
Ischemia
Bone Marrow
Inflammation
Morbidity
Mortality

Keywords

  • Estrogen
  • Hormones
  • Sex
  • TNFR1
  • TNFR2

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

TNFR1 signaling resistance associated with female stem cell cytokine production is independent of TNFR2-mediated pathways. / Markel, Troy A.; Crisostomo, Paul R.; Wang, Meijing; Wang, Yue; Lahm, Tim; Novotny, Nathan M.; Tan, Jiangning; Meldrum, Daniel R.

In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 295, No. 4, 10.2008.

Research output: Contribution to journalArticle

@article{19b095c16fdb46f282a28e55bf2483a2,
title = "TNFR1 signaling resistance associated with female stem cell cytokine production is independent of TNFR2-mediated pathways",
abstract = "End-organ ischemia is a common source of patient morbidity and mortality. Stem cell therapy represents a novel treatment modality for ischemic diseases and may aid injured tissues through the release of beneficial paracrine mediators. Female bone marrow mesenchymal stem cells (MSCs) have demonstrated a relative resistance to detrimental TNF receptor 1 (TNFR1) signaling and are thought to be superior to male stem cells in limiting inflammation. However, it is not known whether sex differences exist in TNF receptor 2 (TNFR2)-ablated MSCs. Therefore, we hypothesized that 1) sex differences would be observed in wild-type (WT) and TNFR2-ablated MSC cytokine signaling, and 2) the production of IL-6, VEGF, and IGF-1 in males, but not females, would be mediated through TNFR2. MSCs were harvested from male and female WT and TNFR2 knockout (TNFR2KO) mice and were subsequently exposed to TNF (50 ng/ml) or LPS (100 ng/ml). After 24 h, supernatants were collected and measured for cytokines. TNF and LPS stimulated WT stem cells to produce cytokines, but sex differences were only seen in IL-6 and IGF-1 after TNF stimulation. Ablation of TNFR2 increased VEGF and IGF-1 production in males compared with wild-type, but no difference was observed in females. Female MSCs from TNFR2KOs produced significantly lower levels of VEGF and IGF-1 compared with male TNFR2KOs. The absence of TNFR2 signaling appears to play a greater role in male MSC cytokine production. As a result, male, but not female stem cell cytokine production may be mediated through TNFR2 signaling cascades.",
keywords = "Estrogen, Hormones, Sex, TNFR1, TNFR2",
author = "Markel, {Troy A.} and Crisostomo, {Paul R.} and Meijing Wang and Yue Wang and Tim Lahm and Novotny, {Nathan M.} and Jiangning Tan and Meldrum, {Daniel R.}",
year = "2008",
month = "10",
doi = "10.1152/ajpregu.90508.2008",
language = "English",
volume = "295",
journal = "American Journal of Physiology",
issn = "0193-1857",
publisher = "American Physiological Society",
number = "4",

}

TY - JOUR

T1 - TNFR1 signaling resistance associated with female stem cell cytokine production is independent of TNFR2-mediated pathways

AU - Markel, Troy A.

AU - Crisostomo, Paul R.

AU - Wang, Meijing

AU - Wang, Yue

AU - Lahm, Tim

AU - Novotny, Nathan M.

AU - Tan, Jiangning

AU - Meldrum, Daniel R.

PY - 2008/10

Y1 - 2008/10

N2 - End-organ ischemia is a common source of patient morbidity and mortality. Stem cell therapy represents a novel treatment modality for ischemic diseases and may aid injured tissues through the release of beneficial paracrine mediators. Female bone marrow mesenchymal stem cells (MSCs) have demonstrated a relative resistance to detrimental TNF receptor 1 (TNFR1) signaling and are thought to be superior to male stem cells in limiting inflammation. However, it is not known whether sex differences exist in TNF receptor 2 (TNFR2)-ablated MSCs. Therefore, we hypothesized that 1) sex differences would be observed in wild-type (WT) and TNFR2-ablated MSC cytokine signaling, and 2) the production of IL-6, VEGF, and IGF-1 in males, but not females, would be mediated through TNFR2. MSCs were harvested from male and female WT and TNFR2 knockout (TNFR2KO) mice and were subsequently exposed to TNF (50 ng/ml) or LPS (100 ng/ml). After 24 h, supernatants were collected and measured for cytokines. TNF and LPS stimulated WT stem cells to produce cytokines, but sex differences were only seen in IL-6 and IGF-1 after TNF stimulation. Ablation of TNFR2 increased VEGF and IGF-1 production in males compared with wild-type, but no difference was observed in females. Female MSCs from TNFR2KOs produced significantly lower levels of VEGF and IGF-1 compared with male TNFR2KOs. The absence of TNFR2 signaling appears to play a greater role in male MSC cytokine production. As a result, male, but not female stem cell cytokine production may be mediated through TNFR2 signaling cascades.

AB - End-organ ischemia is a common source of patient morbidity and mortality. Stem cell therapy represents a novel treatment modality for ischemic diseases and may aid injured tissues through the release of beneficial paracrine mediators. Female bone marrow mesenchymal stem cells (MSCs) have demonstrated a relative resistance to detrimental TNF receptor 1 (TNFR1) signaling and are thought to be superior to male stem cells in limiting inflammation. However, it is not known whether sex differences exist in TNF receptor 2 (TNFR2)-ablated MSCs. Therefore, we hypothesized that 1) sex differences would be observed in wild-type (WT) and TNFR2-ablated MSC cytokine signaling, and 2) the production of IL-6, VEGF, and IGF-1 in males, but not females, would be mediated through TNFR2. MSCs were harvested from male and female WT and TNFR2 knockout (TNFR2KO) mice and were subsequently exposed to TNF (50 ng/ml) or LPS (100 ng/ml). After 24 h, supernatants were collected and measured for cytokines. TNF and LPS stimulated WT stem cells to produce cytokines, but sex differences were only seen in IL-6 and IGF-1 after TNF stimulation. Ablation of TNFR2 increased VEGF and IGF-1 production in males compared with wild-type, but no difference was observed in females. Female MSCs from TNFR2KOs produced significantly lower levels of VEGF and IGF-1 compared with male TNFR2KOs. The absence of TNFR2 signaling appears to play a greater role in male MSC cytokine production. As a result, male, but not female stem cell cytokine production may be mediated through TNFR2 signaling cascades.

KW - Estrogen

KW - Hormones

KW - Sex

KW - TNFR1

KW - TNFR2

UR - http://www.scopus.com/inward/record.url?scp=57349160364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57349160364&partnerID=8YFLogxK

U2 - 10.1152/ajpregu.90508.2008

DO - 10.1152/ajpregu.90508.2008

M3 - Article

C2 - 18685063

AN - SCOPUS:57349160364

VL - 295

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0193-1857

IS - 4

ER -